Skip to main content

Advertisement

SpringerLink
Log in

Feasibility of Breast Preserving Therapy with Single Fraction In Situ Radiotherapy Delivered Intraoperatively

  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Background

Accelerated partial breast irradiation (APBI) has gained widespread interest as a means of improving the convenience and availability of breast conserving radiotherapy. Intraoperative radiation therapy (IORT) is an APBI technique that delivers breast radiotherapy as a single dose at the time of partial mastectomy. We adapted the technique of Veronesi to deliver IORT prior to tumor excision to improve delivery to the region at risk and reduce the volume of normal tissue irradiated.

Methods

Patients age ≥55 with ultrasonographically defined tumors ≤3 cm and invasive ductal carcinoma confirmed by core biopsy were eligible. Pre-operative ultrasound was performed at the time of needle localization and radiocolloid injection. IORT treatment planning was performed prior to surgery using ultrasound tumor definition, selecting cone size and electron energy to optimize dose distribution. In the operating room, the surgeon retracted the skin over the tumor, cone was placed and radiotherapy delivered. Standard partial mastectomy was then performed.

Results

Twenty-three patients were enrolled in the study. Eighteen patients completed IORT with 10 patients having successful IORT no additional local therapy necessary. In five patients, the intraoperative radiation therapy served as the boost and in three patients unsuspected larger tumors or multicentric disease necessitated a mastectomy. The majority of patients had a good to excellent cosmetic result.

Conclusions

Single fraction in situ IORT prior to partial mastectomy is feasible for patients with small breast cancers in achieving a good to excellent cosmetic result. Based on this early preliminary data, we plan to expand our feasibility trial.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

FIG. 1.
FIG. 2.
FIG. 3.

Similar content being viewed by others

References

  1. Veronesi U, Luini A, Del Vecchio M, et al. Radiotherapy after breast-preserving surgery in women with localized cancer of the breast. N Engl J Med 1993; 328(22):1587–91

    Article  PubMed  CAS  Google Scholar 

  2. Clark RM, Whelan T, Levine M, et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. Ontario Clinical Oncology Group. J Natl Cancer Inst 1996; 88(22):1659–64

    Article  PubMed  CAS  Google Scholar 

  3. Liljegren G, Holmberg L, Bergh J, et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 1999; 17(8):2326–33

    PubMed  CAS  Google Scholar 

  4. Fisher B, Anderson S, Redmond CK, et al. Reanalysis and results after 12 years of follow-up in a randomized clinical trial comparing total mastectomy with lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med 1995; 333(22):1456–61

    Article  PubMed  CAS  Google Scholar 

  5. NIH consensus conference. Treatment of early-stage breast cancer. JAMA 1991; 265(3):391–5

    Article  Google Scholar 

  6. The National Institutes of Health Consensus Development Conference: adjuvant therapy for breast cancer. Bethesda, Maryland, USA, November 1–3, 2000. Proc J Natl Cancer Inst Monogr 2000; 30:1–152

    Google Scholar 

  7. Nattinger AB, Hoffmann RG, Kneusel RT, et al. Relation between appropriateness of primary therapy for early-stage breast carcinoma and increased use of breast-conserving surgery. Lancet 2000; 356(9236):1148–53

    Article  PubMed  CAS  Google Scholar 

  8. Morrow M, White J, Moughan J, et al. Factors predicting the use of breast-conserving therapy in stage I and II breast carcinoma. J Clin Oncol 2001; 19(8):2254–62

    PubMed  CAS  Google Scholar 

  9. Hillner BE, McDonald MK, Penberthy L, et al. Measuring standards of care for early breast cancer in an insured population. J Clin Oncol 1997; 15(4):1401–8

    PubMed  CAS  Google Scholar 

  10. Hebert-Croteau N, Brisson J, Latreille J, et al. Compliance with consensus recommendations for the treatment of early stage breast carcinoma in elderly women. Cancer 1999; 85(5):1104–13

    Article  PubMed  CAS  Google Scholar 

  11. Hebert-Croteau N, Brisson J, Latreille J, et al. Variations in the treatment of early-stage breast cancer in Quebec between 1988 and 1994. CMAJ 1999; 161(8):951–5

    PubMed  CAS  Google Scholar 

  12. Ballard-Barbash R, Potosky AL, Harlan LC, et al. Factors associated with surgical and radiation therapy for early stage breast cancer in older women. J Natl Cancer Inst 1996; 88(11):716–26

    Article  PubMed  CAS  Google Scholar 

  13. Riley GF, Potosky AL, Klabunde CN, et al. Stage at diagnosis and treatment patterns among older women with breast cancer: an HMO and fee-for-service comparison. JAMA 1999; 281(8):720–6

    Article  PubMed  CAS  Google Scholar 

  14. Potosky AL, Merrill RM, Riley GF, et al. Breast cancer survival and treatment in health maintenance organization and fee-for-service settings. J Natl Cancer Inst 1997; 89(22):1683–91

    Article  PubMed  CAS  Google Scholar 

  15. Veronesi U, Marubini E, Mariani L, et al. Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial. Ann Oncol 2001; 12(7):997–1003

    Article  PubMed  CAS  Google Scholar 

  16. Clark RM, Wilkinson RH, Miceli PN, MacDonald WD. Breast cancer. Experiences with conservation therapy. Am J Clin Oncol 1987; 10(6):461–8

    Article  PubMed  CAS  Google Scholar 

  17. Vicini F, Arthur D, Polgar C, Kuske R. Defining the efficacy of accelerated partial breast irradiation: the importance of proper patient selection, optimal quality assurance, and common sense. Int J Radiat Oncol Biol Phys 2003; 57(5):1210–3

    PubMed  Google Scholar 

  18. Smith TE, Lee D, Turner BC, et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 2000; 48(5):1281–9

    PubMed  CAS  Google Scholar 

  19. Sarin R. Partial-breast treatment for early breast cancer: emergence of a new a paradigm. Nat Clin Prac Oncol 2005; 2(1):40–47

    Article  Google Scholar 

  20. Pawlik TM, Buchholz TA, Kuerer HM. The biologic rationale for and emerging role of accelerated partial breast irradiation for breast cancer. J Am Coll Surg 2004; 199(3):479–92

    Article  PubMed  Google Scholar 

  21. Wallner P, Arthur D, Bartelink H, et al. Workshop on partial breast irradiation: state of the art and the science, Bethesda, MD, December 8–10, 2002. J Natl Cancer Inst 2004; 96(3):175–84

    Article  PubMed  CAS  Google Scholar 

  22. Orecchia R, Ciocca M, Lazzari R, et al. Intraoperative radiation therapy with electrons (ELIOT) in early-stage breast cancer. Breast 2003; 12(6):483–90

    Article  PubMed  CAS  Google Scholar 

  23. Veronesi U, Gatti G, Luini A, et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg (Chicago, IL: 1960) 2003; 138(11):1253–6

    Google Scholar 

  24. Albertini JJ, Lyman GH, Cox C, et al. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer. JAMA 1996; 276(22):1818–22 [see Comments]

    Article  PubMed  CAS  Google Scholar 

  25. Stitzenberg KB, Calvo BF, Iacocca MV, et al. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am J Clin Pathol 2002; 117(5):729–37

    PubMed  Google Scholar 

  26. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000; 180(4):299–304

    Article  PubMed  CAS  Google Scholar 

  27. Kuske RR, Bolton JS, McKinnon WMP. 5-Year results of a prospective phase II trial of wide-volume brachytherapy as the sole method of breast irradiation in Tis, T1, T2, N0-1 breast cancer. Int J Radiat Oncol Biol Phys 1998; 42:181 [Abstract]

    Google Scholar 

  28. Perera F, Engel J, Holliday R, et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a Pilot Study. J Surg Oncol 1997; 65(4):263–7

    Article  PubMed  CAS  Google Scholar 

  29. Baglan KL, Martinez AA, Frazier RC, et al. The use of high-dose-rate brachytherapy alone after lumpectomy in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2001; 50(4):1003–11

    Article  PubMed  CAS  Google Scholar 

  30. Arthur DW, Koo D, Zwicker RD, et al. Partial breast brachytherapy after lumpectomy: low-dose-rate and high-dose-rate experience. Int J Radiat Oncol Biol Phys 2003; 56(3):681–9

    PubMed  Google Scholar 

  31. Kuske RR, Winter K, Arthur DW, et al. A phase II trial of brachytherapy alone following lumpectomy for stage I or II breast cancer: initial outcomes of RTOG 9517. Proc J Clin Oncol 2004; 22(14S):S565 [abstract]

    Google Scholar 

  32. Edmundson GK, Vicini FA, Chen PY, et al. Dosimetric characteristics of the MammoSite RTS, a new breast brachytherapy applicator. Int J Radiat Oncol Biol Phys 2002; 52(4):1132–9

    PubMed  Google Scholar 

  33. Keisch M, Vicini F, Kuske RR, et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003; 55(2):289–93

    PubMed  Google Scholar 

  34. Vicini FA, Remouchamps V, Wallace M, et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 2003; 57(5):1247–53

    PubMed  Google Scholar 

  35. Formenti SC, Truong MT, Goldberg JD, et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 2004; 60(2):493–504

    PubMed  Google Scholar 

  36. Thames HD Jr, Withers HR, Peters LJ, Fletcher GH. Changes in early and late radiation responses with altered dose fractionation: implications for dose-survival relationships. Int J Radiat Oncol Biol Phys 1982; 8(2):219–26

    PubMed  Google Scholar 

  37. Matthews JH, Meeker BE, Chapman JD. Response of human tumor cell lines in vitro to fractionated irradiation. Int J Radiat Oncol Biol Phys 1989; 16(1):133–8

    PubMed  CAS  Google Scholar 

  38. Williams MV, Denekamp J, Fowler JF. A review of alpha/beta ratios for experimental tumors: implications for clinical studies of altered fractionation. Int J Radiat Oncol Biol Phys 1985; 11(1):87–96

    PubMed  CAS  Google Scholar 

  39. Yamada Y, Ackerman I, Franssen E, et al. Does the dose fractionation schedule influence local control of adjuvant radiotherapy for early stage breast cancer? Int J Radiat Oncol Biol Phys 1999; 44(1):99–104

    Article  PubMed  CAS  Google Scholar 

  40. Wazer DE, Lowther D, Boyle T, et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 2001; 50(1):107–11

    PubMed  CAS  Google Scholar 

  41. King TA, Bolton JS, Kuske RR, et al. Long-term results of wide-field brachytherapy as the sole method of radiation therapy after segmental mastectomy for T(is,1,2) breast cancer. Am J Surg 2000; 180(4):299–304

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

UNC Breast SPORE P50 CA58223, CIS K08 CA83753.

Author information

Authors and Affiliations

  1. Department of Surgery, UNC Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, 3010 Old Clinic Building, CB #7213, Chapel Hill, NC, 27599-7213, USA

    David W. Ollila MD, Nancy Klauber-DeMore MD & Leora J. Tesche MD

  2. Department of Radiology, UNC Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7213, USA

    Cherie M. Kuzmiak DO & Dag Pavic MD

  3. Department of Radiation Oncology, UNC Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7213, USA

    Lav K. Goyal MD, Jun Lian MD, Sha Chang MD & Carolyn I. Sartor MD

  4. Department of Pathology, UNC Lineberger Comprehensive Cancer Center, The University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599-7213, USA

    Chad A. Livasy MD

Authors
  1. David W. Ollila MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Nancy Klauber-DeMore MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Leora J. Tesche MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Cherie M. Kuzmiak DO
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Dag Pavic MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Lav K. Goyal MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Jun Lian MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Sha Chang MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Chad A. Livasy MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Rachel F. Sherron BSN, OCN
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Carolyn I. Sartor MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to David W. Ollila MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ollila, D.W., Klauber-DeMore, N., Tesche, L.J. et al. Feasibility of Breast Preserving Therapy with Single Fraction In Situ Radiotherapy Delivered Intraoperatively. Ann Surg Oncol 14, 660–669 (2007). https://doi.org/10.1245/s10434-006-9154-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-006-9154-1

Keywords

Search

Navigation